Nur Buyru

1.3k total citations
63 papers, 1.0k citations indexed

About

Nur Buyru is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Nur Buyru has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Nur Buyru's work include Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (13 papers) and Cancer-related Molecular Pathways (10 papers). Nur Buyru is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (13 papers) and Cancer-related Molecular Pathways (10 papers). Nur Buyru collaborates with scholars based in Türkiye and United States. Nur Buyru's co-authors include Nejat Dalay, Onur Baykara, Turgut Ulutin, Kamil Kaynak, Filiz Türe Özdemir, Emin Karaman, Ateş Karateke, Semra Demokan, Hakan Çoksüer and Mahmut Müslümanoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Nur Buyru

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nur Buyru Türkiye 18 605 291 201 158 158 63 1.0k
Guillermo Pita Spain 20 427 0.7× 350 1.2× 255 1.3× 119 0.8× 217 1.4× 42 1.1k
Ya‐Sian Chang Taiwan 21 700 1.2× 251 0.9× 388 1.9× 140 0.9× 77 0.5× 71 1.2k
Ki Cheol Park South Korea 23 673 1.1× 333 1.1× 184 0.9× 90 0.6× 222 1.4× 49 1.4k
Petra Kleiblová Czechia 18 463 0.8× 323 1.1× 199 1.0× 175 1.1× 283 1.8× 47 1.0k
Hiroyasu Kashima Japan 24 575 1.0× 296 1.0× 267 1.3× 165 1.0× 191 1.2× 41 1.3k
S V Nicosia United States 14 690 1.1× 295 1.0× 273 1.4× 150 0.9× 215 1.4× 31 1.3k
Quan Li China 14 551 0.9× 169 0.6× 231 1.1× 87 0.6× 322 2.0× 45 1.1k
Gerald Schmid Austria 16 578 1.0× 387 1.3× 145 0.7× 73 0.5× 66 0.4× 27 889
Georgia Sotiropoulou‐Bonikou Greece 16 445 0.7× 252 0.9× 210 1.0× 137 0.9× 324 2.1× 36 973
Riet van der Meer United States 15 806 1.3× 209 0.7× 194 1.0× 125 0.8× 208 1.3× 18 1.4k

Countries citing papers authored by Nur Buyru

Since Specialization
Citations

This map shows the geographic impact of Nur Buyru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nur Buyru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nur Buyru more than expected).

Fields of papers citing papers by Nur Buyru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nur Buyru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nur Buyru. The network helps show where Nur Buyru may publish in the future.

Co-authorship network of co-authors of Nur Buyru

This figure shows the co-authorship network connecting the top 25 collaborators of Nur Buyru. A scholar is included among the top collaborators of Nur Buyru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nur Buyru. Nur Buyru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köseoğlu, Hikmet, et al.. (2021). No Tumor Suppressor Role for LKB1 in Prostate Cancer. DNA and Cell Biology. 40(9). 1222–1229. 1 indexed citations
2.
Buyru, Nur, et al.. (2020). Silencing of Wwox Increases Nuclear Import of Dvl proteins in Head and Neck Cancer. Journal of Cancer. 11(14). 4030–4036. 3 indexed citations
3.
Yener, Murat, et al.. (2019). The investigation of hyaluronic acid and hyaluronidase‐1 levels as tumour marker in larynx cancer. Clinical Otolaryngology. 44(6). 914–918. 5 indexed citations
4.
Ulutin, Turgut, et al.. (2018). Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma. BMC Cancer. 18(1). 477–477. 7 indexed citations
5.
Baykara, Onur, et al.. (2017). The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis. International Journal of Medical Sciences. 14(7). 675–679. 13 indexed citations
6.
Baykara, Onur, et al.. (2017). CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC). Gene. 618. 65–68. 15 indexed citations
7.
Baykara, Onur, et al.. (2017). CT120: A New Potential Target for c-Myc in Head and Neck Cancers. Journal of Cancer. 8(5). 880–886. 5 indexed citations
8.
Baykara, Onur, et al.. (2015). Amplification of Chromosome 8 Genes in Lung Cancer. Journal of Cancer. 6(3). 270–275. 33 indexed citations
9.
Karaman, Emin, et al.. (2015). Epigenetic and Genetic Alterations Affect the WWOX Gene in Head and Neck Squamous Cell Carcinoma. PLoS ONE. 10(1). e0115353–e0115353. 17 indexed citations
10.
Tunç, Murat, et al.. (2012). LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer. Molecular Carcinogenesis. 52(8). 660–665. 12 indexed citations
11.
Özdemir, Filiz Türe, et al.. (2012). Methylation of tumor suppressor genes in ovarian cancer. Experimental and Therapeutic Medicine. 4(6). 1092–1096. 56 indexed citations
12.
Işın, Mustafa, Mustafa Nuri Yenerel, Melih Aktan, Nur Buyru, & Nejat Dalay. (2011). Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia. DNA and Cell Biology. 31(5). 777–782. 5 indexed citations
13.
Karaman, Emin, et al.. (2010). Genetic Alterations of the LKB1 Gene in Head and Neck Cancer. DNA and Cell Biology. 29(12). 735–738. 9 indexed citations
14.
Buyru, Nur, et al.. (2009). Methylation Profiles in Breast Cancer. Cancer Investigation. 27(3). 307–312. 25 indexed citations
15.
Langaee, Taimour, Feng Huang, Nur Buyru, et al.. (2008). VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients. European Journal of Clinical Pharmacology. 64(9). 889–894. 44 indexed citations
16.
Ateş, Ömer, et al.. (2007). Factor V Leiden, Prothrombin G20210A, and Protein C Mutation Frequency in Turkish Venous Thrombosis Patients. Clinical and Applied Thrombosis/Hemostasis. 14(4). 415–420. 19 indexed citations
17.
Özkara, Çiğdem, Mustafa Uzan, Taner Tanrıverdi, et al.. (2006). Lack of association between IL-1β/α gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure. 15(5). 288–291. 23 indexed citations
18.
Buyru, Nur, et al.. (2006). Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer. 6(1). 115–115. 52 indexed citations
19.
Buyru, Nur, et al.. (2005). Molecular Analysis of the P27/Kip1 Gene in Breast Cancer. Molecular Diagnosis. 9(1). 17–21. 10 indexed citations
20.
Yenı, Seher Naz, Çiğdem Özkara, Nur Buyru, et al.. (2005). Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. European Journal of Neurology. 12(2). 103–107. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026